Chem Sci 11:58815888 Tang M, Cai J-H, Diao H-Y, Guo W-M, Yang X, Xing S (2022) The progress of peptide vaccine clinical trials in gynecologic oncology
GHK-Cu works its magic deep within your skins layers, going beyond surface-level fixes to address the core processes of skin health and repair
Canadian Regulatory Context GHK-Cu occupies an interesting regulatory position in Canada
The majority of the panel concluded that allowing licensed compounding pharmacies to produce certain peptides may be preferable to leaving patients to obtain them from an unregulated gray market
Warnings: Risk of Methemoglobinemia: Monitor patients for signs, especially those with risk factors such as G6PD deficiency
Why this matters for peptide buyers The reconstitution solvent isn't a minor detail